YKL-40 is involved in remodelling and angiogenesis in non-cardiac inflammatory diseases. Aim was to quantitate plasma YKL-40 in patients with ST-elevation myocardial infarction (STEMI) or stable chronic coronary artery disease (CAD), and YKL-40 gene activation in human myocardium.
Medical Department B, Cardiac Catheterization Laboratory, The Heart Centre, Rigshospitalet, University Hospital Copenhagen, Faculty of Health Sciences, University of Copenhagen, Denmark.